ArticleFrontiers in oncology2024

Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis.

Blake J McKinley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.